Testing Methods of Screening for Woman Abuse in Health Care Settings. - Full Text View

Purpose

Recent reviews have identified the need for additional high quality exploratory and evaluative research to understand 1) the actual impact on all women of instituting mass screening procedures versus using indicator-based approaches to identifying woman abuse and 2) the extent to which early identification through screening -- either universal or indicator-based is effective in preventing or ameliorating important outcomes. This is a critical first step in developing a larger randomized controlled trial (RCT) which examines the effectiveness of screening in preventing woman abuse, improving quality of life and other associated outcomes. This study prepares for the RCT by testing the optimal method of administration for the two screening instruments that will be used in the RCT. The administration formats are: computer-based screen, paper and pencil screen and face-to-face screen. They study will also determine recruitment rates.

Condition	Intervention
Domestic Violence	Procedure: Woman Abuse Screening Tool Procedure: Partner Violence Screen Procedure: Computerized screening Procedure: Face to face screening Procedure: Written screening on forms

MedlinePlus related topics:

Domestic Violence

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Open Label, Dose Comparison, Single Group Assignment, Efficacy Study

Official Title:	Testing Screening Formats for Indicator-Based and Universal Screening Measurements in the Identification of Woman Abuse.

Further study details as provided by Hamilton Health Sciences:

Primary Outcome Measures:

disclosure rates for past year exposure to intimate partner violence

Secondary Outcome Measures:

participant satisfaction with completing the instruments
missing data

Estimated Enrollment:	2000
Study Start Date:	May 2004
Estimated Study Completion Date:	February 2005

Eligibility

Ages Eligible for Study:	18 Years to 64 Years
Genders Eligible for Study:	Female

Criteria

Inclusion Criteria:

Women aged 18-64 years
Patients at the health care site
Able to participate in English
Able to separate from accompanying person(s)

Exclusion Criteria:

Too ill to participate
Unable to separate from accompanying person(s)
Unable to speak, read, or write English

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00336297

Locations


Canada, Ontario
	City of Hamilton Public Health and Community Services Department
	Hamilton, Ontario, Canada, L8R 3L5
	Cambridge Memorial Hospital - Emergency Department
	Cambridge, Ontario, Canada
	Victoria Family Medical Centre
	London, Ontario, Canada, N5Z 2C1
	Norfolk General Hospital - Emergency Department
	Simcoe, Ontario, Canada, N3Y 1T7
	Carlisle Medical Centre
	Carlisle, Ontario, Canada, L0R 1H0
	London Health Sciences - Victoria Hospital Clinic 5A
	London, Ontario, Canada, N6A 5W9
	Hamilton Health Sciences Colposcopy Clinic
	Hamilton, Ontario, Canada, L8V 1C3

Sponsors and Collaborators

Hamilton Health Sciences

Ontario Women’s Health Council

Investigators


Principal Investigator:	Harriet L MacMillan, MD, MSc	Hamilton Health Sciences

More Information

Website of the McMaster University Violence Against Women Research Program. This link exits the ClinicalTrials.gov site

Protocol for the subsequent RCT of effectiveness of screening for intimate partner violence. This link exits the ClinicalTrials.gov site

Publications of Results:

MacMillan HL, Wathen CN, Jamieson E, Boyle M, McNutt LA, Worster A, Lent B, Webb M; McMaster Violence Against Women Research Group. Approaches to screening for intimate partner violence in health care settings: a randomized trial. JAMA. 2006 Aug 2;296(5):530-6.

Study ID Numbers:	MacMillan_VAW_Testing_Trial
First Received:	June 9, 2006
Last Updated:	November 28, 2006
ClinicalTrials.gov Identifier:	NCT00336297
Health Authority:	Canada: Ethics Review Committee

Keywords provided by Hamilton Health Sciences:

screening

screening methods

intimate partner violence

ClinicalTrials.gov processed this record on September 05, 2008

Sponsors and Collaborators:	Hamilton Health Sciences Ontario Women’s Health Council
Information provided by:	Hamilton Health Sciences
ClinicalTrials.gov Identifier:	NCT00336297